Factors Associated with Preterm, Early Preterm and Late Preterm Birth in Malawi by Van Den Broek, Nynke et al.
Factors Associated with Preterm, Early Preterm and Late
Preterm Birth in Malawi
Nynke R. van den Broek1*, Rachel Jean-Baptiste1, James P. Neilson2
1Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom, 2Department of Women’s & Children’s
Health, Institute of Translational Medicine, University of Liverpool, United Kingdom
Abstract
Background: Assessment of risk factors for preterm birth in a population with high incidence of preterm birth and HIV
infection.
Methods: Secondary analysis of data for 2,149 women included in a community based randomized placebo controlled trial
for the prevention of preterm birth (APPLe trial (ISRCTN84023116) with gestational age at birth determined through
ultrasound measurement in early pregnancy. Multivariate Logistic Regression analyses to obtain models for three outcome
variables: all preterm, early preterm, and late preterm birth.
Findings: No statistical differences were noted for the prevalence of HIV infection (p = 0.30) or syphilis (p = 0.12) between
women who delivered preterm versus term. BMI (Adjusted OR 0.91 (0.85–0.97); p = 0.005) and weight gain (Adjusted OR 0.89
(0.82–0.97); p = 0.006) had an independent, protective effect. Previous preterm birth doubled the odds of preterm birth
(Adjusted OR 2.13 (1.198–3.80); p = 0.01). Persistent malaria (despite malaria prophylaxis) increased the risk of late preterm
birth (Adjusted OR 1.99 (1.05–3.79); p = 0.04). Age ,20 (Adjusted OR 1.73 (1.03–2.90); p = 0.04) and anemia (Adjusted OR
1.95 (1.08–3.52); p = 0.03) were associated with early preterm birth (,34 weeks).
Conclusions: Despite claims that HIV infection is an important cause of preterm birth in Africa, we found no evidence of an
association in this population (unexposed to anti-retroviral treatment). Persistent malaria was associated with late preterm
birth. Maternal undernourishment and anemia were independently associated with early preterm birth. The study did not
assess whether the link was direct or whether a common precursor such as chronic infection was responsible for both
maternal effects and early labour.
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Introduction
Mortality in the first four weeks of life now accounts for 24–56%
of all deaths among children under five and 75% of these occur in
the first week of life. Of the estimated 4 million neonatal deaths
each year, 99% occur in low income countries [1], and
approximately 35% are attributed to preterm birth [2], making
prematurity the leading direct cause of neonatal mortality. Babies
born prematurely, but who survive the immediate postnatal
period, have an increased risk of death and morbidity during
childhood as well as delay in both growth and development
compared to babies born at term [3].
Globally, around 10–11% of all births, or an estimated 15
million births per year, are estimated to be preterm [4],[5]. The
incidence of preterm birth (before 37 completed weeks or 259 days
of pregnancy) is around 10.6% in North America and 6.2% in
Europe [4]. There are few reliable estimates from developing
countries because of uncertainty around assessment of gestational
age and consequent reliance on low birth weight as a proxy
measure. We have previously reported rates of between 17% and
24% in rural, community based studies from Malawi among
women with anemia[6] and in unselected populations of pregnant
women respectively [7],[8]. Critically, these studies used ultra-
sound for accurate assessment of gestational age. These rates, we
believe, are the highest reported in any unselected population
using ultrasound. A review of reported preterm birth rates from
184 countries found Malawi to have highest rate at 18% [5].
Although the reported rates of preterm birth are highest in sub-
Saharan Africa and the highest absolute number of preterm births
occurs in Asia, there are very limited data on factors associated
with preterm birth in these populations. Preterm birth in these
settings is presumed to be strongly associated with infective
morbidity because burdens of infection are high in these countries,
and because there is strong evidence from in vitro and in vivo
experiments to link infection with preterm labour [9],[10]. HIV
infection has been assumed to be a ‘potent cause of preterm birth’
in Africa [11]. An understanding of the causes of the very high
rates of preterm birth in Malawi may not only be of potential value
to clinicians and policy makers in the local population, but may
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provide more generalisable insights to the clinical and research
communities internationally.
Given the burden of co-morbidities during pregnancy for many
women living in resource poor settings, it is plausible that factors
associated with preterm birth will differ from those in more
affluent populations with better access to health care. The
development of innovative solutions for prevention rely on a
better understanding of cause [12], including the importance of
infection – which is recognized to be more strongly associated with
earlier than later preterm birth [13].
Materials and Methods
A secondary analysis was performed using data collected as part
of the APPLe trial (trial number ISRCTN84023116).
For the APPLe trial, pregnant women attending three rural and
one peri-urban health centres in Southern Malawi were
randomised to a placebo-controlled trial of oral azithromycin
(1 g) given at 16–24 weeks and 28–32 weeks gestation. Gestational
age was determined by ultrasound before week 24. Women and
their infants were followed up until 6 weeks post delivery. The
primary outcome was incidence of preterm delivery, defined as
,37 weeks. Secondary outcomes were mean gestational age at
delivery, perinatal mortality, birthweight, maternal malaria, and
anemia. Analysis was by intention to treat [8]. Since prophylactic
treatment with azithromycin had no statistically significant impact
on any of the outcome measures, including preterm birth and
malarial status, the participants’ data was pooled for secondary
analysis regardless of allocated treatment group.
Pregnant women ,24 weeks gestation (ultrasound dated) were
recruited at their first antenatal visit (booking visit) at which time
they were screened for anemia (Hb,11.0 g/dl by battery operated
HemoCue device), malaria (peripheral parasitaemia on thick
blood film) and syphilis (VDRL). All women who tested positive
for syphilis were treated with benzyl penicillin (1 g i.m.). At the
time the trial was conducted HIV testing was not mandatory and
counseling and testing for HIV was available to all women who
wished to be tested. Treatment to prevent maternal to child
transmission was available at time of delivery as indicated.
All women received iron tablets daily (60 mg elemental iron as
ferrous sulphate) with 0.25 mg folic acid and antimalarial
prophylaxis (two doses of Fansidar: 500 mg sulphadoxine with
25 mg pyrimethamine). Women were seen at 4 weekly intervals
until 32 weeks then 2 weekly until term. At 28–32 weeks, all
women were reassessed for malaria and anemia and treated as
needed. Women returned to the clinic for postnatal visits at 1 and
6 weeks. Community-based follow up was conducted for all
women who failed to return to the antenatal or postnatal clinic as
planned, or for women who withdrew from the study.
For this secondary analysis, three groups of women were
defined: those whose pregnancy resulted in an early or late
preterm birth (gestation 24–36 weeks), and those who delivered at
term (37–41 weeks). Women who delivered after 41 weeks
(postterm) were not included in the analysis. Preterm birth was
subdivided into early preterm (24–33 weeks) and late preterm birth
(34–36 weeks). All women who delivered preterm started labour
spontaneously. Data on the general demographics of the mother
(age, parity, BMI and gestational age at booking, weight gain
between booking and 28–32 week visit), outcome of previous
pregnancy and information about the index delivery, including
type of delivery, place and supervision of delivery was analyzed for
each group. Women found to be anemic (Hb,11.0) or severely
anemic (Hb,8.0) both at booking and during the second visit,
were considered ‘persistently anemic’ or ‘persistently severely
anemic’. Blood tests for malaria (peripheral parasitaemia on thick
blood film) were done both at the booking and second visit with
women positive at both visits considered to have ‘persistent
malaria’.
HIV testing was performed retrospectively (2009) on stored
blood samples (including booking blood sample and sample taken
at 28–32 weeks gestation) using the Biorad GENSCREEN Ultra
HIV Ag-AB kit for detection of HIV p24 antigen and antibodies to
HIV1 and HIV 2.
Data was analyzed using SPSS version 19. Frequencies, means
and medians were used as appropriate to describe characteristics
of all study participants. Women who gave birth to twins were
excluded. Pearson’s Chi Square was used to test for significant
differences in dichotomous variables between women who
delivered preterm versus term, while the Student’s t-test was used
to test differences for normally distributed continuous variables.
The Mann Whitney U/Wilcoxon rank sum test was used to
evaluate statistically significant differences among medians of
variables with non-parametric distributions. This descriptive
analysis was repeated for early and late preterm versus term
birth. Multivariate Logistic Regression (MLR) analyses were
conducted to obtain models for three outcome variables: all
preterm, early preterm, and late preterm births.
For multivariate analysis, all variables for which p,0.10 in the
univariate analyses of the specific outcome variable were
considered important and included in the starting model for the
corresponding multivariate analyses. Using the backwards model
selection method, each model was constructed to initially contain
such variables and any that were clinically relevant. Goodness of
Fit tests (Hosmer and Lemeshow) and deviance statistics were used
to select the best multivariate model for each outcome. Odds
Ratios and 95% Confidence Intervals (CI) were calculated for
each variable that remained in the model. The level of statistical
significance for all analyses was set at a=0.05.
Ethical approval was obtained from the College of Medicine
Research Ethics Committee in Malawi. Informed signed consent
was obtained from each participant after receiving a detailed
explanation in the local language of the purpose of the study. In
line with the Ethics Committee’s instructions, HIV testing was
performed retrospectively on stored blood samples only after the
completion of the trial.
Results
Characteristics of study participants
A total of 2,297 women were recruited into the APPLe trial.
Twenty-nine mothers who had twins were excluded from these
analyses. For singleton pregnancies, data on gestation at birth was
available for a total of 2,149 women. Of these 80.5% (1729/2149)
delivered at term (37–41 weeks), 16.3% (351/2149) delivered
preterm (,37 weeks), and 3.2% (69/2149) delivered postterm
(.41 weeks gestation). Among women who delivered preterm,
75.2% (264/351) were late preterm births (34–36 weeks). Mean
(SD) gestational age at birth was 38.6 (2.5) weeks. (Figure 1)
General characteristics of the study population are given in
Table 1. Mean (SD) age of women included in the study was 23.0
(5.2) years and median (minimum, maximum) reported parity 1
(0,12). The majority of women in this rural population deliver in a
hospital or health centre. The vast majority (93.7%) of deliveries
were spontaneous vaginal deliveries, with very low rates of
caesarean section (5.1%) or instrumental deliveries (forceps or
ventouse) (0.4%). Breech delivery (1.9% vs. 0.6%, p= 0.02) and
delivery at home (15.8% vs. 11.8% p,0.03) were both more likely
Preterm Birth in Malawi
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e90128
to occur in women delivering preterm compared to women
delivering at term.
Factors associated with preterm compared to term births
Table 2 summarizes characteristics of women at booking who
delivered at term (37–41 weeks), preterm (24–36 completed
weeks), early preterm (24–33 weeks) and late preterm (34–36
weeks).
Women who gave birth preterm were more likely to report a
history of previous preterm birth (13.2% vs. 6.1%, p= 0.001) and
previous neonatal death (8.1% vs. 4.1%, p= 0.02) compared to
women who delivered at term. Compared to women who gave
birth at term, a significantly greater proportion of women with
preterm births were less than 20 years old (33.6% vs. 27.9%,
p= 0.03) and had lower mean BMI (22.3 vs. 22.8, p = 0.006).
During pregnancy (Table 3) women who had a preterm birth
had lower mean weight gain (kg) between the first (booking ,24
weeks gestation) and subsequent assessment (28–32 weeks gesta-
tion) (2.95 vs. 3.39, p = 0.008). More women who delivered
preterm were anemic (73.5% vs. 64.2%, p= 0.001) or had malaria
(36.4% vs. 28.5%, p= 0.004) at least once during their pregnancy;
a significantly greater proportion also had persistent malaria (7.5%
vs. 4.7%, p= 0.04). No statistical differences were noted for the
prevalence of syphilis (p = 0.12) or HIV positive status (p = 0.30)
between those who delivered preterm versus term.
Factors associated with early preterm compared to term
births
Compared to women who delivered at term, a greater
proportion of women with early preterm birth were underweight,
with BMI ,18.5 (9.3% vs. 3.2%, p= 0.005), and anemic during
pregnancy (76.7% vs. 64.2%, p= 0.03).
More women with early preterm birth reported a previous
adverse pregnancy outcome including previous preterm delivery
(19.1% vs. 6.1%, p= 0.001) and previous stillbirth (14.9% vs.
5.0%, p= 0.003). Other factors that were potentially important
but of borderline statistical significance (0.05,p#0.10) included
the following: adolescence (age ,20) (37.2% vs. 27.9%, p= 0.07)
severe anemia (14.3% vs. 7.9%, p= 0.10). There were no other
notable differences.
Factors associated with late preterm compared to term
births
Compared to women who delivered at term, women who
delivered late preterm had significantly lower mean BMI at
booking (first antenatal visit) (22.3 vs. 22.8, p= 0.02), and gained
less weight (kgs) between the booking visit and 28–32 week visit
(2.94 vs. 3.39, p = 0.01). Anemia (72.6% vs. 64.5%, p= 0.01) was
more prevalent among women who delivered late preterm.
Similarly, malaria at any time during pregnancy (37.8% vs.
28.5%, p= 0.003) and persistent malaria (8.2% vs. 4.7%, p= 0.02)
Figure 1. Histogram of ultrasound determined gestational age at delivery for women in southern Malawi. (n = 2,149).
doi:10.1371/journal.pone.0090128.g001
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were also more prevalent among women who delivered late
preterm. Late preterm birth was also associated with a history of
previous preterm delivery (11.3% vs. 6.1%, p= 0.02), and neonatal
death (8.0% vs. 4.1%, p= 0.03).
Association with age group approached statistical significance;
age over 40 years was associated with increase in late preterm
compared to term birth (2.0% vs. 0.8%, p= 0.06). Women over 40
were also more likely to report previous preterm birth (6.4% vs
4.1% p=0.08) or a neonatal death (4.5% vs 2.6%, p= 0.08).
In this population, the prevalence of HIV was 26.2% overall
(Table 1) and was not statistically different between women who
delivered at term versus those who delivered preterm (early or
late). While additional analyses revealed statistically significant
associations between HIV and anemia and borderline statistically
significant relationships between HIV and malaria, no significant
interactions were found between HIV, malaria or anemia and any
of the preterm birth categories.
Multivariate analyses
Table 4 shows results of multivariate logistic regression of
factors independently associated with (all) preterm birth, early and
late preterm birth.
For all preterm birth, women with a history of a previous
preterm delivery have more than twice the odds of having a repeat
preterm birth (OR 2.13, 95% CI 1.19 – 3.80, p = 0.01).
With increasing BMI the odds of preterm birth is significantly
reduced (OR 0.91, 95%, CI 0.85–0.97, p= 0.005) and this
association is also seen with weight gain (OR 0.89, 95% CI 0.82–
0.97, p = 0.006).
Variables independently associated with early preterm birth
were; age less than 20 years, anemia and a previous preterm birth.
Adolescent age (age,20) (Adjusted OR 1.73, 95% CI 1.03–2.90,
p = 0.04) increased the odds of an early preterm delivery by more
than 70%. Being anemic at any point during the pregnancy nearly
doubled the odds of early preterm labour (Adjusted OR 1.95, 95%
CI 1.08–3.52, p = 0.03). Having had a previous preterm delivery
increased the odds of an early preterm delivery by more than two
and a half times (Adjusted OR 2.68, 95% CI 1.10 – 6.52,
p = 0.03).
Factors that remained independently associated with late
preterm birth were different to those for early preterm birth and
included: BMI, weight gain and previous preterm birth. We found
that an increased BMI (Adjusted OR 0.91, 95% CI 0.85–0.98,
p = 0.01) and weight gain (Adjusted OR 0.89, 95% CI 0.80–0.96,
p = 0.005) reduced the odds of late preterm birth. Similar to early
preterm, a history of previous preterm birth (Adjusted OR 2.07,
95% CI 1.11–3.86, p= 0.02) doubled the odds of late preterm
birth.
Discussion
This study reports on the factors associated with preterm birth
in an unselected rural pregnant population in Malawi, a country
with the highest reported rate of preterm birth worldwide and with
one in four women HIV positive. To the best of our knowledge,
Table 1. Characteristics of study population (n = 2149 women).
Study Characteristic Characteristic Subcategory n %
Age (years) ,20 617 28.7
0–24 861 40.1
25–29 374 17.4
30–34 200 9.3
35–39 69 3.2
40+ 20 0.9
Parity Primiparous (parity 0) 780 36.3
Multiparous (parity 1–4) 1229 57.2
Grand Multiparous (parity 5+) 140 6.5
BMI BMI (mean, SD) 22.7 (SD= 2.6)
BMI ,18.5 69 3.2
Weight Gain (kg, n = 1502) (mean, SD) 3.3 (SD= 2.1)
Weight Loss (kg, n = 152) (mean, SD) 2.0 (SD= 1.4)
Prevalence of Morbidity Anemia (Hb,11.0) 1324 61.6
Persistent Anemia 436 21.4
Severe Anemia (Hb,8.0) 164 7.6
Persistent Severe Anemia 14 0.7
Malaria (slide positive) 634 29.5
Persistent Malaria 106 4.9
HIV Positive Status 563 26.2
Syphilis (VDRL positive) 150 7.0
Previous pregnancy outcome (n = 1369,
excludes primiparous women)
Previous Preterm birth 100 4.7
Previous Stillbirth 78 3.8
Previous Neonatal Death 65 2.9
doi:10.1371/journal.pone.0090128.t001
Preterm Birth in Malawi
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this is the first study from sub-Saharan Africa to report on the
factors associated with preterm birth for a cohort of women in
which gestational age has been reliably assessed with ultrasound.
Although the incidence of preterm birth can be, as we have
shown, very high in sub-Saharan Africa, there is very little data
based on accurate gestational age assessment using prenatal
ultrasound dating. The absence of relatively expensive ultrasound
equipment is unsurprising in routine clinical assessment in low
resource settings but ultrasound should be essential in future
research studies of preterm birth [14]. Overall, 16.3% of women
(singleton pregnancies only) included in this secondary analysis
had a preterm birth with the majority of these (75%) being late
preterm births between 34 and 36 weeks.
The incidence of preterm birth in our population is almost
identical to recently reported, ultrasound-dated figures from a
clinical trial in Botswana – 16.7% [15]. These incidences are
substantially higher than figures from elsewhere in the world and
deserve exploration of cause.
It has been assumed that infective morbidity (including infection
with HIV) is largely responsible for higher rates of preterm birth in
Africa compared with other regions [11]. In fact, we were unable
to demonstrate any impact of HIV infection on preterm birth. Our
study was performed at a time when there was considerable stigma
associated with HIV infection in the study site community [16]
and anti-retroviral (ARV) drugs were largely inaccessible in the
country. Although women recruited into the study had the option
of getting HIV testing and counseling, none did and we are
unaware of any woman in the study taking ARV therapy during
pregnancy. In accordance with the directions of the research ethics
committee, we did not test blood samples for HIV status during
the study. These were only tested retrospectively well after
completion of the trial.
This is, therefore, a unique cohort of pregnant women with a
high incidence of HIV positivity (26.2%), accurate ultrasound
dating of gestational age, but no ARV treatment. In this cohort,
we found no evidence that HIV status affects the risk of preterm
birth. Such a study would not now be possible with the (very
welcome) changes in this community of women having access to
ARV treatment and therefore requesting HIV testing. Whilst there
remains controversy as to whether ARVs (or certain classes of
ARVs) increase the risk of preterm birth or not [17], this is a
confounder that would make it impossible now to undertake a
similar study to assess the direct effects of HIV infection on
gestation at birth. Our finding fits with the findings of a pre-ARV
study of pregnancy outcome in South Africa in which maternal
HIV infection also did not increase the risk of preterm birth
(although in the South African study, gestational age was not
ultrasound-determined) [18].
The implication is that, whatever other advantages stem from
ARV use in HIV infected pregnant women in Malawi, there is no
evidence from the study suggesting that reducing the risk of
preterm birth is one.
Some factors that we did find to be associated with preterm
birth have been recognized in other populations. Thus, a history of
previous preterm birth independently and significantly increased
the odds of preterm birth overall (OR 2.13, 95% CI 1.19–3.80,
p = 0.01); late preterm birth (OR 2.07, 95% CI 1.11–3.86,
p = 0.02) and early preterm birth (OR 2.68, 95% CI 1.10–6.52,
p = 0.03).
Similarly, persistent malaria was associated with a doubling of
the risk of preterm birth.
Although up to 30% of women had peripheral malaria
parasitaemia at the time of booking, all women received
presumptive treatment for malaria and persistent malaria was
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not common in this population (5%). However, if present,
persistent parasitaemia was associated with increased odds for
preterm birth. There has been discussion about the adequacy of
sulphadoxine-pyrimethamine intermittent preventative treatment,
given increasing parasitic resistance [19] as well as whether
prophylaxis should commence earlier in pregnancy, and the
importance of simultaneous bed net use.
There was also an association with poor maternal nutritional
state (low BMI and reduced weight gain) and, for early preterm
birth, maternal anemia. We found that maternal weight played a
significant role in the risk for all preterm birth, though differently
for early versus late preterm. The odds of preterm birth were
increased nearly three-fold for those who were underweight (BMI
,18.5) at booking (even when controlled for HIV positive status),
while the odds of late preterm were decreased if the patient gained
weight (in between booking and the second visit) or increased her
BMI, demonstrating a protective effect of weight against late
preterm birth.
Results obtained in our study are similar to those reported in a
recent large systematic review and meta-analysis on maternal
underweight that pooled data from 52 cohort studies and 26 case
control studies mostly from developed countries and showed an
increased risk of preterm birth in underweight women [20]. An
increased risk of preterm birth in association with low BMI has
been described in the UK (and elsewhere) as an independent
factor alongside social deprivation and smoking [21].
These findings raise the question of whether preterm birth can
be prevented by improving maternal nutrition. A Cochrane review
[22] identified 5 trials, involving 3384 women, of nutritional
supplementation with preterm birth as an outcome measure; the
effect (relative risk 0.96, 95% CI 0.80, 1.16) did not suggest benefit
but only two of the trials took place in low income countries and
only one of these was in Africa [23]. The possibility of benefit from
better nutrition therefore remains an open question, suitable for
future research.
The mechanisms are unclear but both low BMI and anemia
may have common cause in poor nutrition or chronic infection or
both. Maternal anemia is recognized as an important risk factor
for the mother, particularly if she has a postpartum haemorrhage.
Our findings suggest that maternal anemia should also be
recognized as a risk factor for preterm birth.
All women who took part in this study attended for antenatal
care on at least one occasion but the study did not include women
who did not access care until after 24 weeks or who did not access
antenatal care at all. However, in this setting, more than 90% of
pregnant women do attend for antenatal care [24] and we believe
this cohort is representative of the population in many similar
settings in sub-Saharan Africa.
Because HIV testing was performed retrospectively on stored
samples, CD4 counts were not obtained and no information was
available about severity of HIV infection. Parasitic infection (other
than malaria) was not assessed in this cohort. We have previously
noted that hookworm and other parasites were uncommon in this
population [25]. Similarly, we were unable to test for urinary tract
infections or sexually transmitted infections other than HIV and
syphilis in this cohort at the time. Further research is needed to
assess the burden of co-morbidities in pregnant women in this type
of setting with an examination of the relationship of these with
pregnancy outcome.
Conclusions
Preterm birth remains a significant risk factor for neonatal
mortality. Developing a deeper understanding of the factors
significantly associated with preterm birth in a community with an
extremely high incidence and particularly identifying those factors
that are modifiable, could help develop new approaches to
antenatal (and pre pregnancy) care to prevent adverse pregnancy
outcome. Our findings have underscored the importance of
women’s pregnancy history and identified maternal underweight,
malaria and anemia as risk factors for preterm birth. Unexpect-
edly, we found no evidence that HIV status contributes to the risk
of preterm birth.
Acknowledgments
The authors would like to thank Dr Sarah White, Department of
Community Health, College of Medicine, Blantyre, Malawi contributed to
the statistical analysis.
Author Contributions
Conceived and designed the experiments: NVDB JPN. Performed the
experiments: NVDB. Analyzed the data: RJB NVDB. Wrote the paper:
NVDB RJB JPN.
References
1. Lawn JE, Cousens S, Zupan J (2005) 4 million neonatal deaths: When? Where?
Why? Lancet 365:5–11.
2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, et al. (2012) Global, regional,
and national causes of child mortality: an updated systematic analysis for 2010
with time trends since 2000. Lancet 379:2151–2161.
3. Gladstone M, Neilson JP, White S, Kafulafula G, van den Broek N (2011) Post-
neonatal mortality, morbidity, and developmental outcome after ultrasound-
dated preterm birth in rural Malawi: A community-based cohort study. PLoS
Med 8:e1001121.
4. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, et al. (2010) The worldwide
incidence of preterm birth: a systematic review of maternal mortality and
morbidity. Bull World Health Organ 88:31–38.
5. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, et al. (2012)
National, regional, and worldwide estimates of preterm birth rates in the year
2010 with time trends since 1990 for selected countries: a systematic analysis and
implications. Lancet 379:2162–2172.
6. van den Broek NR, White SA, Flowers C, Cook JD, Letsky EA, et al. (2006)
Randomised trial of vitamin A supplementation in pregnant women in rural
Malawi found to be anaemic on screening by HemoCue. Brit J Obstet Gynaec
113:569–576.
7. van den Broek N, Ntonya C, Kayira E, White S, Neilson JP (2005) Preterm birth
in rural Malawi: high incidence in ultrasound-dated population. Hum Reprod
20:3235–3237.
8. van den Broek NR, White SA, Goodall M, Ntonya C, Kayira E, et al. (2009)
The APPLe study: a randomized, community-based, placebo-controlled trial of
azithromycin for the prevention of preterm birth, with meta-analysis. PLoS Med
6:e1000191.
9. Steer P (2005) The epidemiology of preterm labor - a global perspective. J Perinat
Med 33:273–276.
10. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and
causes of preterm birth. Lancet 371:75–84.
11. Steer PJ (2006) The epidemiology of preterm labour-why have advances not
equated to reduced incidence? Brit J Obstet Gynaec 113:1–3.
12. Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, et al. (2013)
Preventing preterm births: analysis of trends and potential reductions with
interventions in 39 countries with very high human development index. Lancet
381:223–234.
13. Kramer MS, Papageorghiou A, Culhane J, Bhutta Z, Goldenberg RL, et al.
(2012) Challenges in defining and classifying the preterm birth syndrome.
Am J Obstet Gynecol 206:108–112.
14. Goldenberg Rl, Gravett MG, Iams J, Papageorghiou AT, Waller SA, et al.
(2012) The preterm birth syndrome: issues to consider in creating a classification
system. Am J Obstet Gynecol 206:113–118.
15. Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, et al. (2011) Increased
risk of preterm delivery among HIV-infected women randomized to protease
versus nucleoside reverse transcriptase inhibitor-based HAART during preg-
nancy. J Infect Dis 204:506–514.
Preterm Birth in Malawi
PLOS ONE | www.plosone.org 7 March 2014 | Volume 9 | Issue 3 | e90128
16. van den Akker T, Bemelmans M, Ford N, Jemu M, Diggle E, et al. (2012) HIV
care need not hamper maternity care: a descriptive analysis of integration of
services in rural Malawi. Brit J Obstet Gynaec 119:431–438.
17. Kourtis AP, Fowler MG (2011) Antiretroviral use during pregnancy and risk of
preterm delivery: More questions than answers. J Infect Dis 204:493–494.
18. Ndirangu J, Newell M L, Bland R M, Thorne C (2012) Maternal HIV infection
associated with small-for-gestational age infants but not preterm births: evidence
from rural South Africa. Hum Reprod 27:1846–1856.
19. McGready R, White NJ, Noster F (2011) Parasitological efficacy of antimalarials
in the treatment and prevention of falciparum malaria in pregnancy 1998 to
2009: a systematic review. Brit J Obstet Gynaec 118:123–135.
20. Han Z, Mulla S, Beyene J, Liao G, McDonald SD (2011) Maternal underweight
and the risk of preterm birth and low birth weight: a systematic review and meta-
analyses. Int J Epidemiol 40:65–101.
21. Taylor-Robinson D, Agarwal U, Yoxall B, Diggle PJ, Platt MJ, et al. (2011)
Quantifying the impact of deprivation on preterm births: A retrospective cohort
study. PLoS ONE 6: e23163.
22. Ota E, Tobe-Gai R, Mori R, Farrar D (2012) Antenatal dietary advice and
supplementation to increase energy and protein intake. Cochrane database of
systematic reviews 9: CD000032.
23. Huybregts L, Roberfroid D, Lanou H, Menten J, Meda N, et al. (2009) Prenatal
food supplementation fortified with multiple micronutrients increases birth
length: a randomized controlled trial in rural Burkina Faso. Am J Clin Nutr
90:1593–1600.
24. van den Broek NR, White SA, Ntonya C, Ngwale M, Cullinan TR, et al. (2003)
Reproductive health in rural Malawi: a population-based survey. Brit J Obstet
Gynaec 110:902-908.
25. van den Broek NR & Letsky EA (2000) Etiology of anemia in pregnancy in south
Malawi. Am J Clin Nutr 72:pp. 247S–256S.
Preterm Birth in Malawi
PLOS ONE | www.plosone.org 8 March 2014 | Volume 9 | Issue 3 | e90128
